關於這一集
MAPS speaks with Tim Mikhelashvili, PharmD, CEO & Co-Founder, Amedea Pharma, Inc. and Riaz Abbas, Learning and Performance Lead, JAPAC Medical, Amgen about innovative approaches to Medical Affairs External Education.
英語
美國
在這一集裡
逐字稿 🔗
Are you the producer of this podcast?
Add a podcast transcript
Need Audio-to-Text?
Transcribe with Listen411 in Just 60 Seconds
本 Podcast 中的其他單集
In Part 2 of this 3-part series, experts from the MAPS Leadership and Management Domain continue this discussion on understanding change. How does it impact our teams, and how can our leaders guide their teams through change?
Through this episode, Medical Affairs professionals may gain a better und…
Welcome to Episode 1 of the SciTech Critical Evaluation of Literature and AI Series: “Evidence Unlocked: Separating Gold from Gravel"
Not all evidence is created equal, so how do you separate gold from gravel? Join experts from the MAPS Scientific & Technical Knowledge Domain for a fast-p…
Building and demonstrating medical impact is becoming a central priority for organizations seeking to deliver meaningful outcomes for patients, healthcare systems, and society. But what does it take to design, implement, and sustain an effective impact framework within a medical affairs setting? In…
Medical affairs teams are implementing AI tools to take advantage of the transformative efficiencies they bring, and successful AI adoption requires responsible AI governance, including managing copyright risk.
In this podcast, Lauren Tulloch, Vice President and Managing Director, CCC, addresses t…
In the final part of this 3-part series, experts from the MAPS Leadership and Management Domain wrap up their discussion on understanding change. How does it impact our teams, and how can our leaders guide their teams through change?
Through this episode, Medical Affairs professionals may gain a b…
免責聲明: 本頁面嵌入的 Podcast 和封面圖片來自 Medical Affairs Professional Society ,歸其所有者所有,與 Listen Notes, Inc. 無關聯,也未獲得 Listen Notes, Inc. 背書。